688712.SH
北芯生命
SSE · Healthcare · Medical - Specialties · CN
CNY 32.18
−3.13%Year over year
Reported trailing growth
- Revenue
- +57.1%
- EBITDA
- —
- EBIT
- —
- EPS
- +8474.6%
- Free cash flow
- +70.5%
- Operating cash flow
- +91.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +80.3%
- EBITDA
- +415.8%
- EBIT
- +246.5%
- Net income
- +283.5%
- EPS
- +283.3%
- Free cash flow
- +775.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026